Press-release for stocks for takeda pharmaceutical company limited for AZN

| -5.87% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | $92.966 630

| -2.86% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | $135.94 770

| 7.04% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | $93.6375 82K

| -8.14% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $63.0 11K

| 23.77% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | $9.2715 500K

| -16.62% | O: -0.27% H: 0.0% C: -1.17%
TAK | $13.235 0.42% 710K

| -10.58% | O: -0.2% H: 0.14% C: -0.48%
NVS | $93.29 -1.19% 530K

| -7.95% | O: -0.06% H: 0.46% C: 0.29%
GSK | $39.935 -1.4% 900K

| -3.43% | O: -0.69% H: 1.42% C: 1.22%
LLY | $745.04 -0.76% 730K

| 0.65% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.35 -0.33% 2.1M

| -4.71% | O: -0.65% H: 1.63% C: 1.48%
ABBV | $163.42 1.08% 2M

| -8.31% | O: -0.88% H: 1.46% C: 1.13%
SNY | $46.19 0.57% 580K

| -0.55% | O: 1.67% H: 0.0% C: 0.0%
AZN | $68.39 -0.5% 1.1M

| 5.59% | O: -2.81% H: 2.08% C: 1.38%
AMGN | $264.99 -0.2% 410K

| -6.33% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published: 2024-02-14 (Crawled : 02:00) - prnewswire.com
LZAGF | $577.676 25

| 15.54% | O: 3.14% H: 1.92% C: 1.92%
GLAXF | $20.2 510

| -3.81% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | $92.966 630

| -0.01% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | $135.94 770

Professional, Scientific, and T...

| 10.07% | O: 0.87% H: 0.21% C: -2.23%
LZAGY | $58.05 27K

| 16.92% | O: 4.07% H: 1.53% C: 1.45%
TMO | $555.75 -0.38% 380K

| 3.58% | O: 0.56% H: 1.3% C: 1.22%
TAK | $13.235 0.42% 710K

| -8.09% | O: 0.42% H: 1.04% C: 0.97%
JNJ | $144.56 -2.05% 4.3M

| -6.41% | O: -0.91% H: 0.0% C: 0.0%
GSK | $39.935 -1.4% 900K

| -2.15% | O: 0.89% H: 0.41% C: 0.1%
LLY | $745.04 -0.76% 730K

| 1.05% | O: 0.38% H: 2.44% C: 1.54%
BAX | $39.415 -1.56% 640K

| 1.06% | O: 0.33% H: 0.63% C: -0.28%
ABBV | $163.42 1.08% 2M

| -7.33% | O: -0.73% H: 0.0% C: 0.0%
ABT | $109.02 0.12% 1.7M

| -3.27% | O: -0.83% H: 0.66% C: 0.38%
SNY | $46.19 0.57% 580K

| 1.52% | O: -1.1% H: 0.0% C: 0.0%
GLPG | $29.495 -1.02% 84K

| -23.71% | O: -1.72% H: 1.8% C: 1.59%
BIIB | $196.8 170K

| -13.17% | O: 0.16% H: 0.43% C: -2.76%
AZN | $68.39 -0.5% 1.1M

| 12.62% | O: 0.28% H: 0.93% C: 0.75%
AMGN | $264.99 -0.2% 410K

| -8.6% | O: -0.21% H: 0.34% C: 0.07%
report global protein growth market

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 510

| -1.6% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | $135.94 770

| 12.66% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | $9.2715 500K

| -14.31% | O: 0.37% H: 0.74% C: 0.28%
TAK | $13.235 0.42% 710K

| -7.9% | O: 0.14% H: 0.35% C: 0.07%
NVS | $93.29 -1.19% 530K

| -6.09% | O: -0.34% H: 0.23% C: -1.13%
JNJ | $144.56 -2.05% 4.3M

| -5.76% | O: 0.7% H: 0.0% C: 0.0%
GSK | $39.935 -1.4% 900K

| -1.39% | O: 1.22% H: 0.07% C: -0.43%
LLY | $745.04 -0.76% 730K

| 1.83% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.35 -0.33% 2.1M

| -2.49% | O: -0.18% H: 0.48% C: -1.91%
ABBV | $163.42 1.08% 2M

| -6.59% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $14.46 1.83% 160K

| -22.02% | O: -1.15% H: 1.03% C: -1.5%
VRTX | $394.31 -0.77% 210K

| -5.06% | O: -0.28% H: 0.49% C: -0.32%
SNY | $46.19 0.57% 580K

| 1.45% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.42 4.6K

| -6.2% | O: -3.1% H: 1.2% C: -0.8%
INCY | $53.88 0.84% 230K

| -7.62% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $196.8 170K

| -19.59% | O: -3.72% H: 0.58% C: -3.82%
AZN | $68.39 -0.5% 1.1M

| 11.92% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $370.44 -1.55% 94K

| -3.4% | O: -2.3% H: 1.65% C: 0.83%
AMGN | $264.99 -0.2% 410K

| -9.82% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | $9.48 1.7K

| -14.75% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | $135.94 770

| 1.57% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 82K

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $63.0 11K

| 34.73% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | $9.2715 500K

| -14.86% | O: 0.28% H: 0.18% C: 0.0%
TAK | $13.235 0.42% 710K

| -6.92% | O: 0.07% H: 0.42% C: 0.07%
NVS | $93.29 -1.19% 530K

| -8.99% | O: 0.09% H: 0.39% C: -0.36%
JNJ | $144.56 -2.05% 4.3M

| -5.23% | O: 1.47% H: 0.0% C: 0.0%
LLY | $745.04 -0.76% 730K

| 6.49% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.35 -0.33% 2.1M

| -1.52% | O: -0.14% H: 0.35% C: -1.12%
ABBV | $163.42 1.08% 2M

| -5.47% | O: 1.48% H: 0.0% C: 0.0%
VRTX | $394.31 -0.77% 210K

| -4.51% | O: 0.15% H: 2.4% C: 0.56%
SNY | $46.19 0.57% 580K

| 0.73% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $110.13 -0.7% 190K

| -11.07% | O: -0.02% H: 0.0% C: -1.4%
AZN | $68.39 -0.5% 1.1M

| 2.52% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $264.99 -0.2% 410K

| -16.0% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $23.92 -0.42% 190K

| Email alert Add to watchlist
JNJ | $144.56 -2.05% 4.3M

| Email alert Add to watchlist
NBIX | $134.73 2.27% 270K

| Email alert Add to watchlist
SNYNF | $92.966 630

| Email alert Add to watchlist
UCBJY | $63.0 11K

| Email alert Add to watchlist
UCBJF | $126.05 100

| Email alert Add to watchlist
AZNCF | $135.94 770

| Email alert Add to watchlist
PFE A | $25.84 -0.27% 8.9M

| Email alert Add to watchlist
TAK | $13.235 0.42% 710K

| Email alert Add to watchlist
NVSEF | $93.6375 82K

| Email alert Add to watchlist
NVS | $93.29 -1.19% 530K

| Email alert Add to watchlist
BMY | $48.35 -0.33% 2.1M

| Email alert Add to watchlist
AZN | $68.39 -0.5% 1.1M

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
LLY | $745.04 -0.76% 730K

| Email alert Add to watchlist
SNY | $46.19 0.57% 580K

| Email alert Add to watchlist
ABBV | $163.42 1.08% 2M

| Email alert Add to watchlist
report business life global therapeutics

Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published: 2023-06-27 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 510

| 11.2% | O: -1.1% H: 0.0% C: 0.0%
TAK | $13.235 0.42% 710K

| -16.42% | O: -0.95% H: 0.19% C: -0.32%
PFE A | $25.84 -0.27% 8.9M

| -29.76% | O: 0.19% H: 0.11% C: -1.46%
NVS | $93.29 -1.19% 530K

| -5.13% | O: -0.01% H: 0.16% C: -0.32%
JNJ | $144.56 -2.05% 4.3M

| -9.8% | O: 0.03% H: 0.12% C: -0.24%
GSK | $39.935 -1.4% 900K

| 11.66% | O: -0.91% H: 0.56% C: -0.5%
LLY | $745.04 -0.76% 730K

| 65.82% | O: 2.15% H: 1.18% C: 0.43%
BMY | $48.35 -0.33% 2.1M

| -25.13% | O: -0.06% H: 0.46% C: 0.0%
AZN | $68.39 -0.5% 1.1M

| -4.18% | O: -0.21% H: 0.42% C: 0.13%
report business cancer treat global

Global Opioid Induced Constipation Markets to 2030: Revenues, Trends, Competitive Assessment & Intelligence
Published: 2023-06-09 (Crawled : 22:00) - prnewswire.com
BHC | $8.515 -1.33% 380K

| Email alert Add to watchlist
AZN | $68.39 -0.5% 1.1M

| Email alert Add to watchlist
IRWD | $7.84 0.64% 710K

| Email alert Add to watchlist
GSK | $39.935 -1.4% 900K

| Email alert Add to watchlist
GLAXF | $20.2 510

| Email alert Add to watchlist
AZNCF | $135.94 770

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
PFE A | $25.84 -0.27% 8.9M

| Email alert Add to watchlist
TAK | $13.235 0.42% 710K

| Email alert Add to watchlist
VTRS | $11.15 -1.5% 2.3M

| Email alert Add to watchlist
opioid global

Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published: 2023-06-08 (Crawled : 02:00) - prnewswire.com
AZNCF | $135.94 770

| -7.46% | O: 0.07% H: 0.0% C: -1.7%
NVSEF | $93.6375 82K

| 14.25% | O: 1.32% H: 0.0% C: -0.62%
TAK | $13.235 0.42% 710K

| -18.09% | O: -0.62% H: 0.88% C: 0.81%
NVS | $93.29 -1.19% 530K

| -4.15% | O: 1.26% H: 1.08% C: 0.91%
GSK | $39.935 -1.4% 900K

| 17.87% | O: 0.41% H: 0.68% C: 0.64%
LLY | $745.04 -0.76% 730K

| 72.05% | O: -0.11% H: 2.66% C: 2.24%
BMY | $48.35 -0.33% 2.1M

| -25.55% | O: 0.28% H: 0.42% C: -0.05%
BNTX | $86.66 -1.4% 360K

| -19.67% | O: 0.39% H: 0.15% C: -0.79%
AZN | $68.39 -0.5% 1.1M

| -6.25% | O: -0.23% H: 1.83% C: 1.52%
AMGN | $264.99 -0.2% 410K

| 20.0% | O: 0.0% H: 0.28% C: -0.23%
metabolic report cancer global therapeutics growth market

Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published: 2023-06-01 (Crawled : 22:00) - prnewswire.com
SNYNF | $92.966 630

| -8.33% | O: -0.56% H: 0.0% C: 0.0%
AZNCF | $135.94 770

| -7.96% | O: -0.74% H: 1.4% C: 0.35%
NVSEF | $93.6375 82K

| 15.61% | O: 0.99% H: 0.0% C: 0.0%
TAK | $13.235 0.42% 710K

| -17.05% | O: 1.32% H: 0.31% C: 0.12%
PFE A | $25.84 -0.27% 8.9M

| -31.85% | O: 0.6% H: 1.07% C: 0.29%
NVO | $123.64 -0.21% 1.4M

| -21.57% | O: -1.84% H: 1.62% C: 1.33%
NVS | $93.29 -1.19% 530K

| -2.78% | O: 1.03% H: 0.84% C: 0.82%
BMY | $48.35 -0.33% 2.1M

| -25.0% | O: 0.37% H: 1.34% C: 1.14%
SNY | $46.19 0.57% 580K

| -6.71% | O: 1.05% H: 0.0% C: 0.0%
AZN | $68.39 -0.5% 1.1M

| -5.64% | O: 0.11% H: 0.69% C: -0.45%
report global therapeutics growth market

Endometriosis Drugs Global Market Report 2023: Emerging Treatments for Endometriosis & Endometrial Cancer Present Opportunities
Published: 2023-03-11 (Crawled : 04:20) - prnewswire.com
ALPMF | $9.48 1.7K

| Email alert Add to watchlist
TAK | $13.235 0.42% 710K

| Email alert Add to watchlist
AZNCF | $135.94 770

| Email alert Add to watchlist
OBSV | $0.1018 -15.52% -18.95% 8.2M

| Email alert Add to watchlist
AZN | $68.39 -0.5% 1.1M

| Email alert Add to watchlist
ABBV | $163.42 1.08% 2M

| Email alert Add to watchlist
ALPMY | $9.2715 500K

| Email alert Add to watchlist
global report cancer market

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
CMXHF | $180.75 33

| -7.93% | O: -0.86% H: 0.33% C: 0.33%
CSLLY | $89.5 44K

| -9.64% | O: -0.02% H: 0.54% C: -1.7%
AZNCF | $135.94 770

| 4.41% | O: -2.57% H: 1.62% C: 1.62%
TMO | $555.75 -0.38% 380K

| -0.12% | O: 0.41% H: 0.39% C: -2.14%
TEVA | $13.09 -1.06% 3.2M

| 33.5% | O: -1.21% H: 0.43% C: -3.58%
TAK | $13.235 0.42% 710K

| -15.73% | O: 0.83% H: 0.06% C: -1.2%
PRGO A | $30.15 0.07% 400K

| -18.48% | O: 0.76% H: 1.91% C: 1.26%
GSK | $39.935 -1.4% 900K

| 17.56% | O: 0.32% H: 0.17% C: -1.53%
LLY | $745.04 -0.76% 730K

| 135.38% | O: 0.01% H: 0.42% C: -2.62%
CTLT | $55.945 -0.24% 180K

| -21.39% | O: 0.11% H: 0.53% C: -5.05%
BMY | $48.35 -0.33% 2.1M

| -29.59% | O: 0.41% H: 0.04% C: -1.71%
ALB | $115.525 -4.13% 1.8M

Process Industries

| -53.09% | O: -0.95% H: 1.02% C: -2.19%
ABBV | $163.42 1.08% 2M

| 4.12% | O: 0.19% H: 0.06% C: -1.7%
SNY | $46.19 0.57% 580K

| -1.8% | O: 0.65% H: 0.0% C: 0.0%
GILD | $67.64 -0.16% 1.2M

| -16.47% | O: 0.23% H: 0.0% C: -1.25%
BIIB | $196.8 170K

| -27.18% | O: 0.28% H: 0.0% C: -2.26%
AZN | $68.39 -0.5% 1.1M

| 6.46% | O: 0.9% H: 0.28% C: -1.3%
global report market

Opioid Induced Constipation (OIC) Drugs Market to Reach USD 1.79 billion, Globally, by 2031 at 4.9% CAGR: Allied Market Research
Published: 2023-02-24 (Crawled : 16:00) - prnewswire.com
MNK | News | $0.3402 -0.06% 540K

| -95.41% | O: 6.42% H: 0.04% C: -4.87%
AZNCF | $135.94 770

| 0.89% | O: -1.25% H: 0.59% C: 0.59%
TAK | $13.235 0.42% 710K

| -16.69% | O: -2.47% H: 0.0% C: -0.32%
NVS | $93.29 -1.19% 530K

| 9.09% | O: -0.25% H: 0.03% C: -0.81%
BHC | $8.515 -1.33% 380K

| -12.39% | O: -0.81% H: 1.28% C: -2.05%
AZN | $68.39 -0.5% 1.1M

| 1.97% | O: -0.98% H: 0.16% C: -0.55%
research opioid market

Antacids Global Market Report 2023
Published: 2023-02-20 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 510

| Email alert Add to watchlist
AZN | $68.39 -0.5% 1.1M

| Email alert Add to watchlist
AZNCF | $135.94 770

| Email alert Add to watchlist
TAK | $13.235 0.42% 710K

| Email alert Add to watchlist
ABT | $109.02 0.12% 1.7M

| Email alert Add to watchlist
GSK | $39.935 -1.4% 900K

| Email alert Add to watchlist
global report market

Global Gastrointestinal Therapeutics Market Report 2022: Sector to Reach $45.9 Billion by 2028 at a 3.8% CAGR
Published: 2023-01-30 (Crawled : 17:00) - prnewswire.com
AZNCF | $135.94 770

| 4.71% | O: 1.09% H: 2.18% C: -1.43%
TAK | $13.235 0.42% 710K

| -17.78% | O: -0.19% H: 0.13% C: -0.69%
PFE A | $25.84 -0.27% 8.9M

| -40.83% | O: 0.0% H: 0.79% C: -0.55%
JNJ | $144.56 -2.05% 4.3M

| -12.27% | O: -0.18% H: 0.36% C: -3.53%
ABT | $109.02 0.12% 1.7M

| -0.96% | O: -0.13% H: 0.78% C: 0.0%
AZN | $68.39 -0.5% 1.1M

| 4.88% | O: 1.3% H: 0.06% C: -0.81%
global report gastrointestinal therapeutics market

The Worldwide Lysosomal Disease Treatment Industry is Expected to Reach $11 Billion by 2028
Published: 2023-01-13 (Crawled : 13:00) - prnewswire.com
SNYNF | $92.966 630

| -6.43% | O: -0.13% H: 0.76% C: 0.76%
AZNCF | $135.94 770

| -1.96% | O: 2.77% H: 0.63% C: 0.63%
TAK | $13.235 0.42% 710K

| -16.26% | O: 0.13% H: 2.35% C: 2.16%
PFE A | $25.84 -0.27% 8.9M

| -45.69% | O: -0.44% H: 1.39% C: 0.74%
NVS | $93.29 -1.19% 530K

| 4.25% | O: 0.15% H: 0.65% C: 0.4%
JNJ | $144.56 -2.05% 4.3M

| -15.18% | O: -0.47% H: 0.47% C: 0.14%
LLY | $745.04 -0.76% 730K

| 109.06% | O: 0.13% H: 1.04% C: 0.57%
SNY | $46.19 0.57% 580K

| -3.09% | O: 1.89% H: 0.0% C: 0.0%
BMRN S | $91.105 -0.44% 270K

| -19.42% | O: -1.16% H: 2.27% C: 0.42%
AZN | $68.39 -0.5% 1.1M

| -1.93% | O: 1.27% H: 0.78% C: 0.15%
treatment disease expected

Global Head And Neck Cancer Therapeutics Market Report 2022: Sector to Reach $2.5 Billion by 2028 at a 12.3% CAGR
Published: 2023-01-12 (Crawled : 22:00) - prnewswire.com
SNYNF | $92.966 630

| -6.43% | O: -0.13% H: 0.76% C: 0.76%
AZNCF | $135.94 770

| -1.96% | O: 2.77% H: 0.63% C: 0.63%
TAK | $13.235 0.42% 710K

| -16.26% | O: 0.13% H: 2.35% C: 2.16%
LLY | $745.04 -0.76% 730K

| 109.06% | O: 0.13% H: 1.04% C: 0.57%
SNY | $46.19 0.57% 580K

| -3.09% | O: 1.89% H: 0.0% C: 0.0%
AZN | $68.39 -0.5% 1.1M

| -1.93% | O: 1.27% H: 0.78% C: 0.15%
global report therapeutics cancer market

Pediatric Vaccine Global Market to Reach Over $57.5 Billion by 2026
Published: 2022-08-24 (Crawled : 15:20) - prnewswire.com
GLAXF | $20.2 510

| 19.74% | O: -1.84% H: 0.0% C: -1.36%
SNYNF | $92.966 630

| 9.37% | O: -4.66% H: 0.0% C: -1.69%
AZNCF | $135.94 770

| 2.21% | O: 0.02% H: 0.0% C: -3.77%
TAK | $13.235 0.42% 710K

| -5.32% | O: -0.79% H: 0.98% C: 0.72%
NVO | $123.64 -0.21% 1.4M

| 16.26% | O: 1.01% H: 2.53% C: 2.2%
GSK | $39.935 -1.4% 900K

| 20.07% | O: -1.27% H: 0.99% C: 0.69%
SNY | $46.19 0.57% 580K

| 14.5% | O: -1.48% H: 0.0% C: 0.0%
AZN | $68.39 -0.5% 1.1M

| 3.46% | O: 0.11% H: 1.8% C: 1.71%
global vaccine market

Red Biotechnology Market to Exceed US$ 609.6 Bn by 2031: TMR Study
Published: 2022-08-19 (Crawled : 14:00) - prnewswire.com
AZNCF | $135.94 770

| 4.43% | O: 3.04% H: 0.12% C: -2.22%
TAK | $13.235 0.42% 710K

| -7.05% | O: -2.05% H: 0.29% C: 0.07%
PFE A | $25.84 -0.27% 8.9M

| -46.67% | O: 0.54% H: 1.24% C: 0.63%
BMY | $48.35 -0.33% 2.1M

| -34.58% | O: 0.01% H: 2.09% C: 1.58%
REGN | $895.57 -0.33% 180K

| 43.81% | O: -0.62% H: 0.57% C: -0.42%
GILD | $67.64 -0.16% 1.2M

| 3.94% | O: -0.25% H: 1.19% C: 0.49%
AZN | $68.39 -0.5% 1.1M

| 3.35% | O: 0.78% H: 0.49% C: 0.22%
study market

LAMEA Peptide Therapeutics Market Report 2022: Annual Growth of 12.5% Expected Through 2028
Published: 2022-08-05 (Crawled : 15:20) - prnewswire.com
LZAGF | $577.676 25

| -3.05% | O: -4.5% H: 0.0% C: 0.0%
GLAXF | $20.2 510

| -2.01% | O: -6.04% H: 2.59% C: 2.59%
SNYNF | $92.966 630

| -4.57% | O: 3.16% H: 0.0% C: 0.0%
AZNCF | $135.94 770

Professional, Scientific, and T...

| 1.95% | O: 0.59% H: 0.0% C: -4.45%
LZAGY | $58.05 27K

| -4.18% | O: -3.78% H: 0.57% C: 0.36%
TAK | $13.235 0.42% 710K

| -5.38% | O: -0.65% H: 0.29% C: 0.0%
PFE A | $25.84 -0.27% 8.9M

| -48.03% | O: -0.44% H: 0.66% C: -0.75%
NVS | $93.29 -1.19% 530K

| 10.77% | O: -0.16% H: 0.71% C: 0.56%
GSK | $39.935 -1.4% 900K

| -0.25% | O: -1.26% H: 1.36% C: 1.2%
LLY | $745.04 -0.76% 730K

| 145.52% | O: -1.08% H: 0.94% C: -0.38%
SNY | $46.19 0.57% 580K

| -5.06% | O: -0.32% H: 0.0% C: 0.0%
AZN | $68.39 -0.5% 1.1M

| 3.68% | O: -0.63% H: 0.63% C: 0.24%
report expected therapeutics growth market

Global Cancer Therapies Market Report 2022: Market to Reach $209.2 Billion by 2026 - Industry Focuses on New Approaches to Treat Cancer
Published: 2022-08-03 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 510

| -1.46% | O: -1.22% H: 1.8% C: 1.8%
AZNCF | $135.94 770

| 4.33% | O: 2.52% H: 0.0% C: -0.19%
NVSEF | $93.6375 82K

| 28.56% | O: -2.88% H: 0.0% C: -0.21%
TAK | $13.235 0.42% 710K

| -5.11% | O: -0.29% H: 0.72% C: 0.58%
PFE A | $25.84 -0.27% 8.9M

| -48.03% | O: 0.08% H: 0.29% C: -0.08%
NVS | $93.29 -1.19% 530K

| 11.25% | O: 0.2% H: 0.44% C: 0.24%
JNJ | $144.56 -2.05% 4.3M

| -14.47% | O: 1.4% H: 0.0% C: 0.0%
GSK | $39.935 -1.4% 900K

| -0.78% | O: 0.27% H: 0.1% C: -0.81%
LLY | $745.04 -0.76% 730K

| 139.23% | O: -1.16% H: 0.02% C: -1.42%
BMY | $48.35 -0.33% 2.1M

| -33.54% | O: -0.27% H: 0.22% C: -0.92%
AZN | $68.39 -0.5% 1.1M

| 5.22% | O: 1.13% H: 0.35% C: 0.35%
global report cancer market

← Previous
1
2
Next →

Gainers vs Losers

51%

49%

Top 10 Gainers

WISA 4 | $7.86 349.14% 120M

Electronic Technology

TPET | $0.4951 114.24% 29M

PRSO | $1.99 56.69% 52M

PALI | $6.5 56.25% 22M

JAGX | $0.1767 48.74% 430M

SXTC | $2.03 45.0% 27M

DYNT | $0.5255 41.87% 18M

SPCB | $0.3888 40.87% 27M

Electronic Technology

SNGX | $0.54 39.86% 7.3M